The Surgical Infection Society (SIS) invites infection preventionists to be a part of an expert discussion that will explore the latest developments in the field of healthcare-associated infections (HAIs) and the impact they have on patients, healthcare providers and the healthcare system overall.
The educational forum provides a unique opportunity for you to hear directly from some of the leading clinical experts in the field as they discuss factors that may motivate change and reduce HAIs, such as financial constraints on reimbursement, mandatory reporting of HAIs and technological advances.
An open and insightful interactive panel discussion that reviews the latest data and guidelines and answers your questions about them. Participants will hear from leading healthcare professionals about the published research and emerging science that influences clinical practice.
HAIs continue to be a major public health concern in the United States, accounting for 50 percent of all major hospital complications at an estimated cost of more than $5.5 billion. SIS is dedicated to educating healthcare providers and patients about HAIs and hopes surgeons can benefit from learning about the latest developments in HAIs.
Serving as moderator will be Lena Napolitano, MD, past-president of SIS. Napolitano is professor of surgery at the University of Michigan School of Medicine, division chief of acute-care surgery, chief of surgical critical care, program director of the Surgical Critical Care Fellowship, and associate chair for the department of surgery.
Also participating is:
- Charles Edmiston, PhD, SM, CIC, professor of surgery and hospital epidemiologist at Froedtert Hospital - Medical College of Wisconsin in Milwaukee, Wis. and adjunct professor at Vanderbilt University School of Medicine in Nashville, Tenn.
- Samir Awad, MD, associate professor in the Michael E. DeBakey Department of Surgery at Baylor College of Medicine in Houston, Texas. He is also director of the surgical ICU at the Veterans Affairs Medical Center in Houston.
The event will be held on Monday, June 6, from 5:30 p.m. to 6:30 p.m. EDT.
To register, visit: http://webcast.streamlogics.com/audience/index.asp?eventid=99625359
The expert discussion is made possible through funding from CareFusion.
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.